Cutaneous protothecosis developed in a 63-year-old Japanese female. The patient had a long history of steroid use for bronchial asthma. A tender, swollen, erythematous plaque with white papules covered the dorsal aspect of the patient's right hand. Histopathological examination showed typical protothecosis with numerous "mulberry-like" sporangia positive for periodic acid-Schiff stain. The pathogen was identified as Prototheca wickerhamii. After a 6-week course of 150-200mg/day itraconazole (ITCZ) therapy, the patient's culture was negative for P. wickerhamii. No recurrence was seen after 12 weeks of ITCZ therapy. This case of protothecosis and those of 16 patients are summarized. All the patients had lived in mid-to southern Japan.
Preface
Prototheca is a genus of microbes that fall between fungi and achlorophyllous mutants of the green alga Chlorella. Such microbes were first found in the slime flux of a deciduous tree. Protothecosis, infection by Prototheca, is quite rare in humans; only about 100 cases have been described in the literature. No standard therapeutic regimen for protothecosis has been established. We report a case of cutaneous protothecosis and review itraconazole (ITCZ) therapy for treatment of this disease.
Case report
A 63-year-old Japanese housewife was referred to our hospital on April 17, 1997. She experienced painful swelling on the dorsal aspect of her right hand. The swelling had first appeared 4 weeks earlier, and spontaneous pain, tenderness, and a localized burning sensation had gradually progressed in spite of treatment with systemic antibiotics and antiallergic agents.
The patient had a long history of receiving systemic steroids for bronchial asthma and showed signs of steroid-induced diabetes and glaucoma. Long-term steroid use had also caused skin atrophy and scarring on the patient's forearms and on the dorsal aspects of both hands.
Physical examination revealed a large erythematous plaque covering the dorsal aspect of the patient's right hand, including the fingers (Fig. 1) . Several white papules were found on the upper surface of the plaque (Fig. 2) . Purulent discharge drained from the papules when they were pricked with a fine needle.
Laboratory examination revealed leukocytosis, C-reactive protein, and increased levels of lactate dehydrogenase, alkaline phosphatase, and total cholesterol. A direct examination in potassium hydroxide preparation of the scales on the plaque found no hyphae or spores.
A sample of a white papule on the plaque was removed for histological examination and culturing on both Sabouraud's dextrose agar medium and mycobacterium medium. Staining with hematoxylin and eosin showed granuloma formation with a central necrotized area surrounded by moderately dense infiltration with lymphocytes, neutrophils, and rare eosinophils (Fig. 3) . The inflammatory cell infiltration extended from the papillary dermis to the deep dermis. The overlying epidermis appeared normal. Periodic acid-Schiff (PAS) stain and Grocott methenamine silver (GMS) stain revealed organisms among the infiltrating cells in the dermis ( Fig. 4) . The internal structure of the organisms was clearer in the samples colored with PAS stain than in those colored with GMS stain because the organisms deeply absorbed the GMS stain. The organisms seen were spores of various sizes and several "mulberry-like" sporangia. Many wet creamy yellow-white colonies similar to those of Candida, a genus of yeast-like fungi, grew on the Sabouraud's dextrose agar medium (Fig. 5) . No colonies grew on the mycobacterium medium.
Microscopic examination of a cultured colony stained with lactophenol cotton blue showed numerous spores and mulberry-like sporangia (Fig. 6 ) identical to those found in the PASstained specimen. The organism was identified as a species of Prototheca on the basis of the morphological findings.
Sugar assimilation tests were performed by API 20C Auxanogram (BlO MERIEUXS S.A., France.
Assimilation was positive for glucose, galactose, and trehalose, but not for n-propranol. On the basis of these results, the organism was identified as Prototheca wickerhamii.
Treatment
After the biopsy procedure, the patient was given 200mg/day minocycline for 9 days without improvement. Once the organism was identified as a species of Prototheca, the patient was given 100 mg itraconazole (ITCZ) twice a day, beginning May 14. When digestive irritation developed a week later, the dosage was changed to 50 mg three times a day, which the patient tolerated better.
By the third week of ITCZ treatment, most of In Japan, 16 cases of human protothecosis have been reported4-18) ( Table 2) , and of these 16, 14 were cutaneous protothecosis. The cases were equally distributed between the sexes and most often found in elderly people. Protothecosis has been reported in temperate and tropical areas around the world; in Japan, all of the patients with protothecosis lived in the mid-to southern portion of the country.
Human protothecosis has been classified into three types: cutaneous, olecranon bursitis, and systemic 6). More than half the number of reported cases of human protothecosis are cutaneous. Most investigators consider protothecosis to be an opportunistic infection because prototheca can be easily cultured from the environment and protothecosis often develops in patients with immunosuppression resulting from circumstances such as topical or systemic steroid therapy and diabetes mellitus 19) .
Cutaneous protothecosis commonly develops on exposed body surfaces, such as the face and limbs 3). The prototheca is believed to enter the body through an open wound 20). Because the wound site is typically small, as it was in our patient, the incubation period of protothecosis is not known. The appearance of the protothecosis lesion may vary from indurating erythema to papulo-pustular eruption, yet localized tenderness is a common feature of the disease. A biopsy of the lesion is required for making a diagnosis. Typical histopathological findings are polymorphous infiltration or granulomatous dermatitis and PAS-positive mulberry-shaped sporangia which are pathognomonic of the disease.
Because protothecosis is an extremely rare disease, no standard therapy for its treatment has 
